Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination
Background: With only one 15 mg primaquine tablet registered by a stringent regulatory authority and marketed, more quality-assured primaquine is needed to meet the demands of malaria elimination. Methods: A classic, two sequence, crossover study, with a 10-day wash out period, of 15 mg of IPCA-prod...
Main Authors: | Nguyen Ngoc Pouplin, J, Kaendiao, T, Rahimi, BA, Soni, M, Basopia, H, Shah, D, Patil, J, Dholakia, V, Suthar, Y, Tarning, J, Mukaka, M, Taylor, WR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2024
|
Similar Items
-
Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination
by: Julie Nguyen Ngoc Pouplin, et al.
Published: (2024-06-01) -
Anti-infectivity efficacy and pharmacokinetics of WHO recommended single low-dose primaquine in children with acute Plasmodium falciparum in Burkina Faso: study protocol
by: Ouédraogo, A, et al.
Published: (2024) -
Anti-infectivity efficacy and pharmacokinetics of WHO recommended single low-dose primaquine in children with acute Plasmodium falciparum in Burkina Faso: study protocol
by: Alphonse Ouédraogo, et al.
Published: (2024-09-01) -
Is it time for Africa to adopt primaquine in the era of malaria control and elimination?
by: Richard O. Mwaiswelo, et al.
Published: (2022-02-01) -
Mass primaquine treatment to eliminate vivax malaria: Lessons from the past
by: Kondrashin, A, et al.
Published: (2014)